Puma Exec's Brother Traded On Cancer Drug Info, SEC Says
The U.S. Securities and Exchange Commission on Wednesday filed a suit in Florida federal court accusing the brother of a Puma Biotechnology Inc. executive of reaping $107,000 in illegal profits through...To view the full article, register now.
Already a subscriber? Click here to view full article